0 108

Cited 0 times in

Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+ early breast cancer

Authors
 H.K. Ahn  ;  K. Park  ;  S.H. Sim  ;  K.J. Suh  ;  M.H. Kim  ;  W-Y. Park  ;  Y-L. Choi  ;  S-A. Im  ;  K.H. Jung  ;  Y.H. Park 
Citation
 ANNALS OF ONCOLOGY, Vol.33(Suppl 3) : S125-S126, 2022-05 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2022-05
Full Text
https://www.sciencedirect.com/science/article/pii/S0923753422003994
DOI
10.1016/j.annonc.2022.03.020
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194506
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links